![](../images/chemdb_main_product.jpg) |
![](../images/title_product_content.gif) |
|
|
|
Tofacitinib Citrate|540737-29-9 |
![](../images/col_chem_composition.gif) |
99.5% |
![](../images/col_cas.gif) |
540737-29-9 |
![](../images/col_uses.gif) |
anti-Arthritis |
![](../images/col_property.gif) |
Tofacitinib Citrate [CAS:540737-29-9]
Intermediates: 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine [cas:3680-69-1] (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride [cas:1062580-52-2] N-Methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [cas:477600-74-1] 3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1- yl]-3-oxopropanenitrile [cas:477600-75-2]
|
Industrial field |
pharmaceutical |
|
|
![](../images/product_title_com.gif) |
|
|
|
![](../images/box_com_top2.gif) |
There are no existing companies to distribute selected chemical product |
|
![](../images/box_com_bottom.gif) |
|
|
|